Galectin Therapeutics News

Buy Rating Affirmed for Galectin Therapeutics Ahead of Phase 2b Interim Analysis and With Strong Cash Position

TipRanksAug 20 16:47

Galectin Therapeutics Analyst Ratings

BenzingaAug 16 18:42

HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $11 Price Target

BenzingaAug 16 18:42

Analysts' Opinions Are Mixed on These Healthcare Stocks: Inogen (INGN) and Galectin Therapeutics (GALT)

TipRanksApr 10 00:15

Galectin Therapeutics Analyst Ratings

BenzingaApr 10 00:01

Buy Rating Affirmed for Galectin Therapeutics Amidst Positive Clinical Trial Progress and Enhanced Financial Stability

TipRanksApr 2 00:30

Galectin Therapeutics Analyst Ratings

BenzingaApr 2 00:25

HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $11 Price Target

BenzingaApr 2 00:25

Arce's Buy Rating on Galectin Therapeutics: Promising NAVIGATE Trial Progress and Strong Financial Outlook

TipRanksNov 14, 2023 19:39

Galectin Therapeutics Analyst Ratings

BenzingaAug 15, 2023 19:16

H.C. Wainwright Remains a Buy on Galectin Therapeutics (GALT)

TipRanksAug 15, 2023 18:36

Analysts' Top Healthcare Picks: Galectin Therapeutics (GALT), Cabaletta Bio (CABA)

TipRanksMay 17, 2023 18:30

HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $11 Price Target

BenzingaMay 17, 2023 18:25

H.C. Wainwright Sticks to Their Buy Rating for Galectin Therapeutics (GALT)

TipRanksApr 1, 2023 00:31

HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $11 Price Target

BenzingaMar 4, 2023 00:55

H.C. Wainwright Sticks to Its Buy Rating for Galectin Therapeutics (GALT)

TipRanksMar 3, 2023 23:36

H.C. Wainwright Sticks to Their Buy Rating for Galectin Therapeutics (GALT)

TipRanksDec 2, 2022 20:05

Analysts Are Bullish on Top Healthcare Stocks: Galectin Therapeutics (GALT), Viridian Therapeutics (VRDN)

TipRanksNov 15, 2022 20:02